Brookfield Corp’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19,526
| Closed | -$1.4M | – | 149 |
|
|
2023
Q2 | $1.4M | Sell |
19,526
-12,074
| -38% | -$868K | 0.01% | 432 |
|
|
2023
Q1 | $1.95M | Buy |
31,600
+20,822
| +193% | +$1.28M | 0.01% | 410 |
|
|
2022
Q4 | $831K | Buy |
+10,778
| New | +$831K | ﹤0.01% | 500 |
|
|
2022
Q3 | – | Sell |
-64,846
| Closed | -$2.48M | – | 619 |
|
|
2022
Q2 | $2.48M | Buy |
+64,846
| New | +$2.48M | 0.01% | 360 |
|